The United States Food and Drug Administration (FDA) recently requested the removal of the dangerous drugs Belviq and Belviq XR (lorcaserin) from the U.S. market. The FDA’s drug safety communication stated that the reason for the request is that a clinical safety trial showed an increased occurrence of cancer.
Call the law firm of Nadrich & Cohen today for a free consultation at 1-800-718-4658 if you or a loved one developed cancer after taking Belviq or Belviq XR. You may be entitled to financial compensation. We only charge a fee if and only if we obtain a recovery.
Dangerous Drug Liability
Companies who manufacture products can be held liable in California for lawsuit damages under the theory of strict liability. Attorneys can recover compensation for damages which defectively designed products and products without adequate warnings cause.
However, pharmaceutical manufacturers are subject to a different set of regulations and rules in California when it comes to product liability laws. The theory of strict liability only applies in California to drug makers when their drugs are improperly made or when manufacturers fail to warn of dangerous side effects when they know about them.
Eisai, the manufacturer of Belviq and Belviq XR, has submitted a request to voluntarily withdraw the drugs. However, the FDA’s drug safety communication notes that the clinical trial which found an increased occurrence of cancer in Belviq and Belviq XR patients was conducted between January 2014 and June 2018. The drugs have remained on the market from June 2018 until the FDA’s request for removal in February 2020. This time gap means that Eisai may have continued to sell the drugs from June 2018 until February 2020 even though they knew the drugs were linked to an increased occurrence of cancer.
If you or a loved one were diagnosed with cancer after taking Belviq or Belviq XR. Contact our law office today for a free, confidential consultation by calling 1-800-718-4658, using the live chat feature, or completing the contact form on this page.
Cancer Risk Of Belviq And Belviq XR
The clinical study which led to the FDA’s request found that 7.7 percent of patients who took lorcaserin were diagnosed with cancer compared to 7.1 percent of patients who took a placebo. The difference resulted from specific cancers including lung, colorectal and pancreatic cancers. The difference increased as the duration of lorcaserin treatment increased. There was no statistical difference over the initial months of treatment.
The dangerous drug lawyers at Nadrich & Cohen have been specializing in representing victims of dangerous drugs since 1990. This vast experience in handling dangerous drug cases has allowed us to obtain several six and seven figure recoveries for our dangerous drug clients. We deal with dangerous drug cases on a daily basis and are currently handling cases against the manufacturers of Oxycontin, Zantac, Truvada, and many more.
How To Join The Belviq Lawsuit
Call Nadrich & Cohen. When experience counts, you need an attorney with a proven track record taking on the powerful pharmaceutical companies. Contact the dangerous drug attorneys of Nadrich & Cohen and find out why we’ve been able to obtain over $350,000,000 on behalf of our clients since 1990.
We operate on a contingency fee basis. This means that there is never any upfront cost to our clients. We only collect a fee for our services if a recover is made.
Call us today for a free consultation at 1-800-718-4658 if you or a loved one was diagnosed with cancer after taking Belviq or Belviq XR. We are a California law firm, but our attorneys handle dangerous drug cases nationwide.